{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:28:49Z","timestamp":1777570129101,"version":"3.51.4"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10,15]]},"DOI":"10.1086\/421961","type":"journal-article","created":{"date-parts":[[2004,10,4]],"date-time":"2004-10-04T14:49:35Z","timestamp":1096901375000},"page":"S224-S227","source":"Crossref","is-referenced-by-count":18,"title":["Combination Therapy for Invasive Mycoses: Evaluation of Past Clinical Trial Designs"],"prefix":"10.1093","volume":"39","author":[{"given":"Jack D.","family":"Sobel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,10,15]]},"reference":[{"key":"key\n\t\t\t\t20171014043725_ref1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1439-0507.1999.00475.x","article-title":"The past, present and future of antimycotic combination therapy","volume":"42","author":"Polak","year":"1999","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20171014043725_ref2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis","volume":"301","author":"Bennett","year":"1979","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014043725_ref3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/clinids\/17.5.837","article-title":"Cryptococcal meningitis and AIDS","volume":"17","author":"Powderly","year":"1993","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014043725_ref4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199201093260202","article-title":"Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group","volume":"326","author":"Saag","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014043725_ref5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/infdis\/165.5.960","article-title":"Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease","volume":"165","author":"White","year":"1992","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014043725_ref6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014043725_ref7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/515110","article-title":"A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis","volume":"28","author":"Saag","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014043725_ref8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-80-2-176","article-title":"Prognostic factors in cryptococcal meningitis: a study in 111 cases","volume":"80","author":"Diamond","year":"1974","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014043725_ref9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/AAC.39.3.598","article-title":"Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B","volume":"39","author":"Sugar","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014043725_ref10","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo vs. fluconazole plus amphotericin B as therapy of candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014043725_ref11","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute","volume":"331","author":"Rex","year":"1994","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014043725_ref12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/513663","article-title":"The epidemiology of hematogenous candidiasis caused by different Candida species","volume":"24","author":"Abi-Said","year":"1997","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014043725_ref13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0002-9343(01)01130-5","article-title":"The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer","volume":"112","author":"Bodey","year":"2002","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171014043725_ref14","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1128\/JCM.39.9.3254-3259.2001","article-title":"International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program","volume":"39","author":"Pfaller","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014043725_ref15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0163-4453(93)92761-K","article-title":"Treatment of Candida albicans fungaemia with fluconazole","volume":"26","author":"Graninger","year":"1993","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20171014043725_ref16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/320876","article-title":"Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses","volume":"33","author":"Rex","year":"2001","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/39\/Supplement_4\/S224\/20905976\/39-Supplement_4-S224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T08:37:30Z","timestamp":1507970250000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/39\/Supplement_4\/S224\/321731\/Combination-Therapy-for-Invasive-Mycoses"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,15]]},"references-count":16,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2004,10,15]]},"published-print":{"date-parts":[[2004,10,15]]}},"URL":"https:\/\/doi.org\/10.1086\/421961","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,10,15]]},"published":{"date-parts":[[2004,10,15]]}}}